Erectile dysfunction (ED) is a common outcome following radical prostatectomy and is most often related to cavernous nerve injury (CNI).
These nerves are part of the autonomic nervous system and play an important role in initiating and maintaining erections. They do this through signalling pathways that regulate blood flow within the penis.
When these nerves are injured, the signalling required for erections becomes disrupted. This does not always cause a complete loss of function. More often, erections become less reliable, more difficult to maintain, or harder to achieve consistently.
While surgery often aims to preserve these nerves, they are extremely delicate. Even minor stretching, pressure, or manipulation during surgery can affect how well they function afterwards.
Importantly, the effects are not limited to the nerves themselves. Neural signalling does more than trigger an erection. It also helps maintain the environment that keeps erectile tissue healthy.
As erections occur less frequently, the erectile tissue receives less oxygenated blood. Over time, this begins to affect how the tissue functions and adapts.
The sections below explore these processes in more detail, including changes in neural signalling, oxygen supply, vascular function, and tissue structure within the corpora cavernosa.
1. Nerve Injury: The First Domino
Erections are initiated through a neurovascular process, meaning they depend on coordinated interaction between nerves and blood vessels.
The cavernous nerves within the penis release nitric oxide. Nitric oxide acts as a signalling molecule, allowing the smooth muscle within the erectile tissue to relax. This relaxation allows blood to flow into the corpora cavernosa and be retained.
When these nerves are injured, this signalling process is disrupted.
Nitric oxide release is reduced. The smooth muscle response becomes less effective. As a result, the initial signal required to produce an erection is weakened.
This does not always result in a complete loss of function. More often, erections become less frequent, less rigid, or more difficult to initiate.
This change affects more than erectile function itself. Erections also play a role in maintaining the health of the tissue. As erections become less frequent, changes within the erectile tissue begin to develop over time.
2. The Role of Erections in Maintaining Tissue Health
Erections are not only functional. They also contribute to the ongoing maintenance of erectile tissue.
Regular erections, including those that occur during sleep, increase the delivery of oxygenated blood to the corpora cavernosa.
This process helps maintain the balance between smooth muscle cells and connective tissue within the erectile chambers.
When erections occur less frequently, this maintenance process is reduced.
As a result, the tissue is exposed to lower levels of oxygen over time.
This concept is explored further here:
3. Penile Hypoxia and Its Downstream Effects
A sustained reduction in oxygen supply within erectile tissue is referred to as penile hypoxia.
Penile hypoxia does not simply reduce energy availability. Oxygen also plays a regulatory role in how the tissue functions.
When oxygen levels remain low:
- Cellular signalling begins to change
- Pathways involved in tissue remodelling become more active
- The balance between smooth muscle and connective tissue begins to shift
One of the key pathways involved is transforming growth factor-beta (TGF-β), which regulates tissue repair and scarring.
4. Structural Change: Smooth Muscle Loss and Fibrosis
As hypoxia persists, structural changes begin to develop within the erectile tissue.
Transforming growth factor-beta (TGF-β) signalling promotes the production of collagen, a structural protein.
At the same time, smooth muscle content within the corpora cavernosa begins to decrease.
Over time, this leads to fibrosis. Fibrosis refers to the accumulation of connective tissue and a reduction in elasticity.
This change affects how the erectile tissue responds during arousal. The corpora cavernosa become less able to expand and compress veins to trap blood effectively.
5. Oxidative Stress and Nitric Oxide Availability
Cavernous nerve injury is also associated with an increase in oxidative stress.
Oxidative stress refers to an imbalance between reactive oxygen species and the body’s ability to regulate them.
This has two main effects. It can directly affect cellular function, and it reduces the availability of nitric oxide.
As nitric oxide levels are already reduced due to nerve injury, this further limits the ability to initiate and maintain an erection.
6. Impaired Vascular Function and VEGF
Vascular endothelial growth factor (VEGF) plays an important role in maintaining blood vessel health and supporting tissue repair.
Following cavernous nerve injury and reduced oxygenation, VEGF signalling may be disrupted.
This can affect blood vessel integrity and reduce the capacity for repair.
As a result, the ability of the erectile tissue to recover normal function may be limited.
7. A Self-Reinforcing Cycle
These processes do not occur in isolation. They interact and influence one another over time.
A simplified sequence can be understood as follows:
- Nerve injury reduces erectile signalling
- Reduced erections lower oxygen levels
- Low oxygen promotes structural change
- Structural change further impairs blood flow and function
Over time, this can form a self-reinforcing cycle that affects both tissue health and erectile function.
This cycle helps explain why early intervention is often discussed in the context of:
➢ Penile Rehabilitation After Prostatectomy
Closing
Understanding these mechanisms does not predict any one individual outcome. However, it provides a framework for understanding how erectile dysfunction can develop and change over time following cavernous nerve injury.
It also helps explain why approaches that support blood flow, oxygenation, and tissue health are often considered during recovery.
Mechanisms of Erectile Dysfunction Following Cavernous Nerve Injury
- Song G, Hu P, Song J, Liu J, Ruan Y. Molecular pathogenesis and treatment of cavernous nerve injury-induced erectile dysfunction: A narrative review. Frontiers in Physiology. 2022;13:1029650. doi:10.3389/fphys.2022.1029650
- Asker H, Yilmaz-Oral D, Oztekin CV, Gur S. An update on the current status and future prospects of erectile dysfunction following radical prostatectomy. The Prostate. 2022;82(12):1135–1161. doi:10.1002/pros.24366
- Novacescu D, Bardan R, Latcu S, et al. The cavernous nerve injury rat model: A pictorial essay on post-radical prostatectomy erectile dysfunction research. Life. 2023;13(12):2337. doi:10.3390/life13122337
- Novacescu D, Nesiu A, Bardan R, et al. Rats, neuregulins and radical prostatectomy: A conceptual overview. Journal of Clinical Medicine. 2023;12(6):2208. doi:10.3390/jcm12062208
- Mubarak A, Ahmad M, Sheikh N, et al. Oxidative stress and erectile dysfunction: Pathophysiology, impacts, and potential treatments. Current Issues in Molecular Biology. 2024;46(8):521. doi:10.3390/cimb46080521
- Ciaccio G, Russo GI, Bernardo A, et al. Erectile dysfunction and oxidative stress: A narrative review. International Journal of Molecular Sciences. 2025;26(7):3073. doi:10.3390/ijms26073073
- Xi Y, Feng Z, Xia T, et al. Caveolin-1 scaffolding domain-derived peptide enhances erectile function by regulating oxidative stress, mitochondrial dysfunction, and apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury. International Journal of Impotence Research. 2024. doi:10.1016/j.urology.2024.05.006
- Schardein JN, Myers JB. Nocturnal penile tumescence devices: Past, present and future. International Journal of Impotence Research. 2024;36(7):693–699. doi:10.1038/s41443-023-00789-z
- Yildirim A, Baser A, Kopru B, et al. Electromyographic analysis of the effects of robotic-assisted and retropubic radical prostatectomy on cavernous nerves and smooth muscles. The Journal of Sexual Medicine. 2025;22(7):1283. doi:10.1093/jsm/vkaf115
- Albersen M, Shindel AW, Mwamukonda KB, Lue TF. The future is today: Emerging drugs for the treatment of erectile dysfunction. Expert Opinion on Emerging Drugs. 2010;15(3):467–480. doi:10.1517/14728214.2010.480973